Comparison of Efficacy in Patients with Metastatic Melanoma Treated with Ipilimumab and Nivolumab Who Did or Did Not Discontinue Treatment Due to Immune-Related Adverse Events: A R...

por Fink, Morten, Vittrup, Anders Schwartz, Bastholt, Lars, Svane, Inge Marie, Donia, Marco, Luczak, Adam A., Ruhlmann, Christina H., Guldbrandt, Louise Mahncke, Koehler, Ulrich Heide, Winther, Mette Lerche, Ellebaek, Eva, Haslund, Charlotte Aaquist, Schmidt, Henrik
Publicado 2021